-
UTI Healthcare IDCW-P
Equity healthcare
Overview ( as on 14/11/25 )
NAV
₹223.98
Last change
₹0.42 +0.0%
Fund Size (AUM)
1124.88 Cr
Performance
17.42% (5Y)
Fund Details
UTI Healthcare IDCW-P
as of 14/11/25
AUM
1124.88 Cr
Expense Ratio
2.26 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01679
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare IDCW-P | 3.97% | 23.68% | 17.42% |
| BSE Healthcare TR INR | 1.4% | 23.01% | 18.25% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.77% |
Ajanta Pharma Ltd |
6.25% |
Lupin Ltd |
5.58% |
Glenmark Pharmaceuticals Ltd |
4.12% |
Cipla Ltd |
3.74% |
Procter & Gamble Health Ltd |
3.67% |
Gland Pharma Ltd |
3.65% |
Apollo Hospitals Enterprise Ltd |
3.62% |
Dr Reddy's Laboratories Ltd |
3.57% |
Alkem Laboratories Ltd |
3.52% |
Sector Allocation
Healthcare |
98.9% |
Basic Materials |
1.1% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
20.65% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
19.96% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
19.35% (5Y)
-
-
SBI Healthcare Opportunities IDCW-R
Equity healthcare-
Returns
-
19.35% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
17.42% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
17.42% (5Y)
-
